HK1101095A1 - Novel oncogene, recombinant protein derived therefrom, and uses thereof - Google Patents
Novel oncogene, recombinant protein derived therefrom, and uses thereofInfo
- Publication number
- HK1101095A1 HK1101095A1 HK07108761.3A HK07108761A HK1101095A1 HK 1101095 A1 HK1101095 A1 HK 1101095A1 HK 07108761 A HK07108761 A HK 07108761A HK 1101095 A1 HK1101095 A1 HK 1101095A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- oncogenic protein
- novel oncogene
- polynucleotide
- protein derived
- seq
- Prior art date
Links
- 108700020796 Oncogene Proteins 0.000 title abstract 4
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 title 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 title 1
- 102000027450 oncoproteins Human genes 0.000 abstract 4
- 108091008819 oncoproteins Proteins 0.000 abstract 4
- 108091033319 polynucleotide Proteins 0.000 abstract 3
- 239000002157 polynucleotide Substances 0.000 abstract 3
- 102000040430 polynucleotide Human genes 0.000 abstract 3
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 239000002773 nucleotide Substances 0.000 abstract 2
- 125000003729 nucleotide group Chemical group 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 206010008342 Cervix carcinoma Diseases 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 208000009608 Papillomavirus Infections Diseases 0.000 abstract 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 abstract 1
- 201000010881 cervical cancer Diseases 0.000 abstract 1
- 210000002919 epithelial cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003011478A JP3792655B2 (ja) | 2003-01-20 | 2003-01-20 | 新規な癌遺伝子、該癌遺伝子由来の組換えタンパク質、およびそれらの用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1101095A1 true HK1101095A1 (en) | 2007-10-05 |
Family
ID=32588600
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK05102336A HK1069850A1 (en) | 2003-01-20 | 2005-03-17 | Novel oncogene, recombinant protein derived therefrom, and uses thereof |
| HK07108761.3A HK1101095A1 (en) | 2003-01-20 | 2007-08-13 | Novel oncogene, recombinant protein derived therefrom, and uses thereof |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK05102336A HK1069850A1 (en) | 2003-01-20 | 2005-03-17 | Novel oncogene, recombinant protein derived therefrom, and uses thereof |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US7358350B2 (xx) |
| EP (1) | EP1439229B9 (xx) |
| JP (1) | JP3792655B2 (xx) |
| CN (3) | CN101608182B (xx) |
| AT (1) | ATE444362T1 (xx) |
| DE (1) | DE602004023340D1 (xx) |
| ES (1) | ES2331995T3 (xx) |
| HK (2) | HK1069850A1 (xx) |
| SG (1) | SG135939A1 (xx) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1884522A1 (en) * | 2006-07-31 | 2008-02-06 | Boehringer Ingelheim International GmbH | Antibody binding to a polo-like kinase 1 phosphorylation site of the human cohesin Wapl |
| CN102154214B (zh) * | 2011-01-29 | 2012-10-17 | 谢幸 | 一种新的宫颈癌细胞株（N-Caski）及其构建方法和应用 |
| CN110114470A (zh) * | 2016-12-27 | 2019-08-09 | 住友化学株式会社 | 诱导的多能性干细胞的评价方法及选择方法、以及诱导的多能性干细胞的制备方法 |
| CN110491450B (zh) * | 2019-08-23 | 2023-05-16 | 深圳市新合生物医疗科技有限公司 | 肿瘤新生抗原预测平台及其应用 |
| CN113057146B (zh) * | 2021-04-06 | 2022-03-18 | 西南大学 | 家蚕BmUAP56基因的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3091870B2 (ja) | 1989-12-19 | 2000-09-25 | アメリカ合衆国 | 肝細胞の癌の癌遺伝子 |
| US6506559B1 (en) * | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
| JP2002524525A (ja) | 1998-09-11 | 2002-08-06 | カリフォルニア・インスティテュート・オブ・テクノロジー | 合成ポリアミドによる発癌遺伝子ＨＥＲ／２ｎｅｕ発現の制御 |
| WO2000042180A1 (fr) | 1999-01-14 | 2000-07-20 | Kyowa Hakko Kogyo Co., Ltd. | Nouvelle proteine |
| AU3395900A (en) | 1999-03-12 | 2000-10-04 | Human Genome Sciences, Inc. | Human lung cancer associated gene sequences and polypeptides |
| JP4520551B2 (ja) | 1999-07-14 | 2010-08-04 | パナソニック株式会社 | 駆動回路および表示装置 |
| JP4426023B2 (ja) | 1999-08-20 | 2010-03-03 | 第一三共株式会社 | 大腸癌抑制遺伝子関連蛋白質 |
| AU3574900A (en) * | 1999-10-15 | 2001-04-23 | Jin Woo Kim | Human cervical cancer 1 protooncogene and protein encoded therein |
| US20040072154A1 (en) * | 2000-12-22 | 2004-04-15 | Morris David W. | Novel compositions and methods for cancer |
| WO2003008583A2 (en) | 2001-03-02 | 2003-01-30 | Sagres Discovery | Novel compositions and methods for cancer |
| KR20020088738A (ko) * | 2001-05-21 | 2002-11-29 | 주식회사 아미노젠 | 암세포 증식 억제 단백질 ｅ2를 생산하는 재조합아데노바이러스 벡터 및 이의 용도 |
| WO2003087768A2 (en) * | 2002-04-12 | 2003-10-23 | Mitokor | Targets for therapeutic intervention identified in the mitochondrial proteome |
| EP1560931B1 (en) * | 2002-11-14 | 2011-07-27 | Dharmacon, Inc. | Functional and hyperfunctional sirna |
-
2003
- 2003-01-20 JP JP2003011478A patent/JP3792655B2/ja not_active Expired - Lifetime
-
2004
- 2004-01-15 SG SG200400188-9A patent/SG135939A1/en unknown
- 2004-01-16 US US10/758,562 patent/US7358350B2/en active Active
- 2004-01-20 CN CN2009101261648A patent/CN101608182B/zh not_active Expired - Lifetime
- 2004-01-20 AT AT04001078T patent/ATE444362T1/de not_active IP Right Cessation
- 2004-01-20 CN CN2006101493302A patent/CN1982324B/zh not_active Expired - Lifetime
- 2004-01-20 EP EP04001078A patent/EP1439229B9/en not_active Expired - Lifetime
- 2004-01-20 CN CNB2004100024479A patent/CN1295331C/zh not_active Expired - Lifetime
- 2004-01-20 ES ES04001078T patent/ES2331995T3/es not_active Expired - Lifetime
- 2004-01-20 DE DE602004023340T patent/DE602004023340D1/de not_active Expired - Lifetime
-
2005
- 2005-03-17 HK HK05102336A patent/HK1069850A1/xx not_active IP Right Cessation
-
2006
- 2006-06-09 US US11/449,671 patent/US7432358B2/en not_active Expired - Lifetime
-
2007
- 2007-08-13 HK HK07108761.3A patent/HK1101095A1/xx not_active IP Right Cessation
-
2008
- 2008-09-09 US US12/207,298 patent/US7893246B2/en not_active Expired - Lifetime
-
2011
- 2011-01-12 US US13/005,198 patent/US20110213128A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN101608182A (zh) | 2009-12-23 |
| EP1439229A3 (en) | 2004-12-01 |
| HK1069850A1 (en) | 2005-06-03 |
| US20060217342A1 (en) | 2006-09-28 |
| ATE444362T1 (de) | 2009-10-15 |
| US20110213128A1 (en) | 2011-09-01 |
| DE602004023340D1 (de) | 2009-11-12 |
| JP2004222539A (ja) | 2004-08-12 |
| US7358350B2 (en) | 2008-04-15 |
| CN1982324B (zh) | 2010-06-09 |
| JP3792655B2 (ja) | 2006-07-05 |
| US20040248155A1 (en) | 2004-12-09 |
| CN1982324A (zh) | 2007-06-20 |
| US7432358B2 (en) | 2008-10-07 |
| ES2331995T3 (es) | 2010-01-22 |
| CN101608182B (zh) | 2011-06-15 |
| CN1295331C (zh) | 2007-01-17 |
| SG135939A1 (en) | 2007-10-29 |
| CN1550550A (zh) | 2004-12-01 |
| EP1439229B1 (en) | 2009-09-30 |
| US20090042830A1 (en) | 2009-02-12 |
| EP1439229B9 (en) | 2010-02-24 |
| US7893246B2 (en) | 2011-02-22 |
| EP1439229A2 (en) | 2004-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL210455A (en) | A polypeptide for reducing mammalian signaling 13il, and using a polypeptide to produce a drug for up-regulating gene expression 2ra13-il in mammals | |
| HK1101095A1 (en) | Novel oncogene, recombinant protein derived therefrom, and uses thereof | |
| IN2014CN02050A (xx) | ||
| MXPA04008077A (es) | Anticuerpos ant-a° y su uso. | |
| TWI265168B (en) | C peptide for improved preparation of insulin and insulin analogs | |
| TW200716166A (en) | Lawsonia intracellularis immunological proteins | |
| ATE521626T1 (de) | Fusionsprotein zur inhibierung von gebärmutterhalskrebs | |
| HK1066241A1 (en) | Kidney-specific urate transporter and gene thereof | |
| EP1602721A4 (en) | PHOSPHOLIPASE A SB 2 / SB ORIGIN MOLD KOJI | |
| GB2356864B (en) | Novel polypeptide | |
| WO2008029138A3 (en) | Peptides and methods | |
| WO2008104575A3 (en) | Immune system mediator | |
| DE60325227D1 (xx) | ||
| EP1627063A4 (en) | INDUCTION OF FLOWER | |
| EP1679372A4 (en) | NEW PLEXIN POLYPEPTIDE, THIS CODING DNA AND USE THEREOF | |
| WO2004013167A3 (en) | Purified polypeptides from enterococcus faecalis | |
| WO2003089461A3 (en) | Purified dutpase from helicobacter pylori | |
| GB0520568D0 (en) | Receptor | |
| TW200702337A (en) | Coronavirus S peptides | |
| CA2340795A1 (en) | Placental organic anion transporter and gene thereof | |
| WO2004069989A3 (en) | Novel purified phosphodiesterase polypeptides | |
| JP2002335976A5 (xx) | ||
| WO2003068970A1 (fr) | Transporteur vehiculant un acide amine acide independamment du sodium et son gene | |
| WO2004058811A3 (en) | Crystal structures of yhhf polypeptides | |
| DE60021707D1 (de) | Beta-primeverosidase gen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PE | Patent expired |
Effective date: 20240123 |